Drug Type Monoclonal antibody |
Synonyms anti-CD20 monoclonal antibodies(Suzhou Genemen Biotech), BF-27, GM-04 |
Target |
Action inhibitors |
Mechanism CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Hodgkin Lymphoma | Preclinical | China | - | |
Non-Hodgkin Lymphoma | Preclinical | China | - |